JulianAdinAbramsMDMS

Esophagus Disease, Gastrointestinal Cancer

Associate Professor, Medicine and Epidemiology, Columbia University College of Phys & Surg

Overview of Dr. Abrams

Dr. Julian Abrams is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 17 years. Dr. Abrams accepts several types of health insurance, listed below. He is one of 302 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.

Office
161 Fort Washington Ave
New York, NY 10032
Book by Phone+1(951) 667-7909

Education & Training

Mailman School of Public HealthM.S., Biostatistics, 2005 - 2007
New York Presbyterian Hospital (Columbia Campus)Fellowship, Gastroenterology, 2003 - 2006
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2000 - 2003
Icahn School of Medicine at Mount SinaiClass of 2000

Certifications & Licensure

NJ State Medical License 2022 - 2025
NY State Medical License 2002 - 2025
American Board of Internal Medicine Gastroenterology

Clinical Trials

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma Start of enrollment: 2005 Oct 01
Recruiting
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus Start of enrollment: 2010 Jun 01
Completed
Phase 2
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation Start of enrollment: 2012 Jan 01
Completed
Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus Start of enrollment: 2011 Sep 01
Terminated
Not Applicable
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium Start of enrollment: 2011 Dec 01
Completed
A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy Start of enrollment: 2013 Apr 01
Terminated
Not Applicable
Use of Radiofrequency Ablation for RGB Salvage Start of enrollment: 2013 Jul 01
Completed
Not Applicable
Effect of Acid Suppression Medication on Pediatric Microbiome Start of enrollment: 2014 Nov 01
Terminated
Not Applicable
The Microenvironment in Barrett's Esophagus Start of enrollment: 2018 Feb 01
Completed
Rapid Assessment of Esophageal Adenocarcinoma Risk Test Start of enrollment: 2018 Aug 01
Suspended
Not Applicable
Longitudinal Oral Microbiome Sampling for BE Start of enrollment: 2021 Mar 19
Recruiting
Roles: Principal Investigator, Contact
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE) Start of enrollment: 2021 Feb 09
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

51 citations
Emerging Insights into the Esophageal Microbiome.
Michael May, Julian A. Abrams
Current Treatment Options in Gastroenterology. 2018-01-19
51 citations
Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
Erik J. Snider, Daniel E. Freedberg, Julian A. Abrams
Digestive Diseases and Sciences. 2016-04-11
54 citations
Notch Signaling Mediates Differentiation in Barrett’s Esophagus and Promotes Progression to Adenocarcinoma
Bettina Kunze, Frederik Wein, Hsin-Yu Fang, Akanksha Anand, Theresa Baumeister
Gastroenterology. 2020-08-01

Lectures

Update in Gastroenterology, Hepatology & Nutrition , 29th Annual Postgraduate Medicine Course
College of Physicians & Surgeons, Columbia University, New York, New York - 11/30/2012

Press Mentions

Can Pepcid Treat COVID-19?June 15th, 2020
Digestive Disease Week 2018: NewYork-Presbyterian Experts Available for InterviewJune 1st, 2018
Acid-Reducing Medications Sharply Raise Risk of C. Difficile Bacteria Infection in KidsJune 17th, 2015

Grant Support

Risk Factors For Site-Specific Metastasis In Esophageal CancerNational Cancer Institute2008–2011

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment